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Summary
Background Depression and anxiety disorders are common mental disorders worldwide. The MANAS trial aimed to 
test the eﬀ ectiveness of an intervention led by lay health counsellors in primary care settings to improve outcomes of 
people with these disorders. 
Methods In this cluster randomised trial, primary care facilities in Goa, India, were assigned (1:1) by computer-
generated randomised sequence to intervention or control (enhanced usual care) groups. All adults who screened 
positive for common mental disorders were eligible. The collaborative stepped-care intervention oﬀ ered case 
management and psychosocial interventions, provided by a trained lay health counsellor, supplemented by 
antidepressant drugs by the primary care physician and supervision by a mental health specialist. The research 
assessor was masked. The primary outcome was recovery from common mental disorders as deﬁ ned by the 
International Statistical Classiﬁ cation of Diseases and Related Health Problems—10th revision (ICD-10) at 6 months. 
This study is registered with ClinicalTrials.gov, number NCT00446407.
Findings 24 study clusters, with an equal proportion of public and private facilities, were randomised equally 
between groups. 1160 of 1360 (85%) patients in the intervention group and 1269 of 1436 (88%) in the control group 
completed the outcome assessment. Patients with ICD-10-conﬁ rmed common mental disorders in the intervention 
group were more likely to have recovered at 6 months than were those in the control group (n=620 [65·0%] vs 553 
[52·9%]; risk ratio 1·22, 95% CI 1·00–1·47; risk diﬀ erence=12·1%, 95% CI 1·6%–22·5%). The intervention had 
strong evidence of an eﬀ ect in public facility attenders (369 [65·9%] vs 267 [42·5%], risk ratio 1·55, 95% CI 
1·02–2·35) but no evidence for an eﬀ ect in private facility attenders (251 [64·1%] vs 286 [65·9%], risk ratio 0·95, 
0·74–1·22). There were three deaths and four suicide attempts in the collaborative stepped-care group and six 
deaths and six suicide attempts in the enhanced usual care group. None of the deaths were from suicide. 
Interpretation A trained lay counsellor-led collaborative care intervention can lead to an improvement in recovery 
from CMD among patients attending public primary care facilities. 
Funding The Wellcome Trust.
Introduction
Depressive and anxiety disorders (the so-called common 
mental disorders) are the leading neuropsychiatric 
cause of the global burden of disease and are associated 
with an increased risk of suicide, increased health-care 
costs, and reduced economic productivity.1–4 The 
prevalence of these disorders varies substantially 
between primary care settings with a mean of 20% from 
a study of 14 countries,5 but recognition of these 
disorders is poor, with less than a third of clinically 
signiﬁ cant cases identiﬁ ed.6 Although evidence of the 
eﬃ  cacy of antidepressant drugs and brief psychological 
treatments for common mental disorders has long been 
available,7–11 there are several obstacles to providing 
eﬀ ective interventions to real-world primary care 
settings in developing countries.12–14 These obstacles 
include the low recognition rate of these disorders by 
primary care doctors, the inadequate use of 
antidepressant drugs or psychosocial treatments, and 
low adherence to treatments. In a systematic review15 of 
the constituents of collaborative care interventions for 
primary care management of these disorders, the use 
of routine screening, the professional skills of staﬀ , and 
specialist supervision predicted a favourable outcome. 
Task shifting is an increasingly advocated method that 
can alleviate shortages in specialist health human 
resources.16,17
We undertook a cluster randomised controlled trial 
(MANAS; MANashanti Sudhar Shodh, which means 
“project to promote mental health” in Konkani) to 
systematically develop an intervention for common 
mental disorders that aimed to address these barriers 
in routine primary health care in Goa, India.18 More 
than half of all primary care consultations in India take 
place in the private sector.19 We aimed to assess the 
eﬀ ectiveness of collaborative stepped-care interventions 
led by lay health counsellors on patients’ recovery from 
common mental disorders in primary health-care 
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settings (both public primary health centre [PHC] 
and private general practitioner [GP] settings) in 
Goa, India. 
Methods
Study design and patients 
This cluster randomised controlled trial was done in two 
consecutive phases from April, 2007, to September, 2009, 
in 12 PHCs (phase 1) and in 12 GP facilities (phase 2). A 
randomised design with the health facility as the unit of 
randomisation was chosen to prevent contamination 
between individuals.
Adults older than 17 years were screened if: they spoke 
Konkani, Marathi, Hindi, or English; did not need 
urgent medical attention; did not have diﬃ  culty with 
hearing, speaking, or cognition, which could make 
interviewing diﬃ  cult; had not already been screened in 
the previous 2 weeks; and were not already receiving the 
intervention. Those who screened positive for common 
mental disorders with the 12-item general health 
questionnaire (GHQ; with a previously validated cutoﬀ  
score of >5)20 and who expected to be resident in Goa for 
the subsequent 12 months were invited to participate in 
the trial. If the patient gave written consent (or verbal 
consent for illiterate individuals), a structured clinical 
diagnostic interview for use by trained lay interviewers 
(the revised clinical interview schedule [CIS-R])21 was 
administered to provide a baseline assessment of 
severity and diagnostic categorisation. 
Details about trial protocol approval and consent have 
been published previously.22 The trial was approved by 
the Institutional Review Boards of the London School of 
Hygiene and Tropical Medicine and Sangath, the Indian 
Council of Medical Research, and an independent Trial 
Steering Committee. In Phase 1, facility consent was 
obtained from the Government of Goa’s Directorate of 
Health Services. In Phase 2, facility consent was obtained 
from each GP. Individual participant consent was 
obtained in two stages: after the screening, those who 
screened positive were invited to participate in the CIS-R 
interview and be enrolled in the trial. Written consent 
was again obtained by the ﬁ eld researcher at the time of 
the outcome assessment.
Randomisation and masking
The sampling frames included all facilities with the space 
and privacy for lay health counsellors, had regular out-
patient clinics, and were not involved in preliminary 
phases of the project. For phase 1, 17 facilities in Goa met 
these inclusion criteria, of which 12 were randomly 
selected for inclusion in the trial. PHC facilities were ﬁ rst 
stratiﬁ ed by the presence or absence of a visiting 
psychiatrist and then randomised within four strata 
deﬁ ned by size. For phase 2, we sent out 400 letters to 
GPs from a list of all registered medical GPs in the state; 
eight responded. The research team then visited a 
purposively selected subsample of GPs who had not 
responded (n=60). Thus, altogether, 68 GPs were visited 
and assessed for eligibility; 25 did not meet our a-priori 
eligibility criteria and 21 declined to participate. 12 of the 
22 eligible GP facilities were randomly selected for 
phase 2 of the trial. The 12 GP facilities were randomised 
within two strata deﬁ ned by size. For both phases, 
facilities were randomly allocated within each stratum 
to either the intervention or control arm using a 
1:1 allocation ratio using a computer-generated random-
isation sequence.
Masking of the research assessor was maximised by: 
undertaking assessments at home; randomly allocating 
unique identiﬁ cation numbers to patients so that there 
was no association between their number and the identity 
of the facility; outcome assessment being done by an 
independent institution whose team did not know the 
randomisation allocation; and undertaking the primary 
outcome assessment before all other assessments. 
Interventions
All interventions were implemented at the individual 
level within clusters. The formative and piloting work 
leading to the design of the collaborative stepped-care 
Suitable recipient Timing Treatment Health worker contact
Initiation of treatment 
(step 1)
Patients screened for common 
mental disorders
At ﬁ rst consultation Advice about results from screening 
questionnaire; advice about seeing 
an LHC; psychoeducation 
Primary care physician; 
LHC
Management of 
moderate or severe 
cases (step 2)
Patients who are severely ill at 
ﬁ rst consultation or whose 
symptoms persist at follow-up
At ﬁ rst consultation or at 
follow-up if not responding to 
step 1
Antidepressant drugs or 
interpersonal psychotherapy; 
adherence management




Patients who remain unwell or 
who are not adherent to 
treatment
Patients who do not respond to 
step 2 despite taking the 
treatment 
Antidepressant drugs and 
interpersonal therapy; adherence 
management
Primary care physician; 
LHC
Referral to specialists 
(step 4)
Patients who do not respond 
despite good adherence or 
who are judged to be at high 
risk of suicide 
Patients who do not respond to 
steps 2 or 3 despite taking the 
treatment and patients who are 
at high risk of suicide at any time
Continue all existing treatments; 
referral to clinical specialist
Clinical specialist
LHC=lay health counsellor.
Table 1: Collaborative-stepped care intervention 
For more on this randomisation 
plan generator see http://www.
randomization.com
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intervention has been described previously.18 In brief, the 
intervention is based on the stepped-care approach, 
which emphasises the eﬃ  cient use of scarce resources. 
The collaborative approach involves three key team 
members: the lay health counsellor, the primary care 
physician, and a visiting psychiatrist (the clinical 
specialist). The locally recruited lay health counsellors 
did not have health backgrounds and underwent a 
structured 2-month training course. Lay health 
counsellors acted as a case-manager for all patients who 
screened positive for common mental disorders, and 
took overall responsibility for delivering all the non-drug 
treatments in close collaboration with the primary care 
physician and the clinical specialist, with the ultimate 
goal of a planned discharge on recovery. Table 1 provides 
the steps of the collaborative stepped-care intervention. 
Psychoeducation provided by the lay health counsellor 
to all patients who screened positive for common mental 
disorders focused on educating the person about their 
symptoms, the association of common mental disorders 
with interpersonal diﬃ  culties, and the need to share 
emotional symptoms with the doctor and to share 
personal diﬃ  culties with family members caring for 
them or other key people in their social network (derived 
from the initial phase of interpersonal psychotherapy). 
Psychoeducation taught patients strategies to alleviate 
symptoms, such as breathing exercises for anxiety 
symptoms and scheduling activities for symptoms of 
depression. Encouraging adherence to treatments for 
these disorders and providing information about social 
and welfare organisations when needed were other key 
components of psychoeducation. Antidepressant drugs 
were recommended only for moderate or severe 
common mental disorders (ie, with a GHQ score >7) 
and for those who did not respond to psychoeducation 
alone on the basis of routine clinical assessments by the 
lay health counsellor. The antidepressant used, 
ﬂ uoxetine, was provided by the project to integrate with 
the existing model of free drugs prescribed by the PHC 
doctor. In the GP clinics, doctors could prescribe 
antidepressant drugs of their choice, from recom-
mendations oﬀ ered in a manual that provided 
information about commonly available drugs and their 
side-eﬀ ects and costs,23 which were purchased by 
patients as usual. Once initiated, antidepressant drugs 
were recommended for a minimum of 90 days at an 
adequate dose (at least 20 mg per day of ﬂ uoxetine or 
the equivalent, which could be titrated up to 40 mg if 
clinical response was inadequate). Physicians were 
given training for half a day and a manual. The other 
key roles of the physicians were to encourage patients to 
meet the lay health counsellor, to avoid the use of 
unnecessary drugs, and to provide usual care for any 
coexisting physical health problems.
Interpersonal psychotherapy, delivered by the lay health 
counsellor, was the structured psychological intervention 
chosen because of its documented feasibility and 
eﬀ ectiveness in Uganda, another low-income country,24 
and because of its focus on interpersonal problems such 
as grief, disputes, and role transitions, which were 
common in the adverse life experiences of participants in 
previous research in Goa.25 A minimum of six sessions, 
with an optimum of eight and a maximum of 12, were 
oﬀ ered. Interpersonal psychotherapy was reserved only 
for patients who had moderate or severe common mental 
disorders, and was oﬀ ered as an alternative to or in 
addition to antidepressant drugs for those who did not 
respond to antidepressant treatment. 
Referral to the clinical specialist was reserved for 
patients who were assessed as having a high suicide risk 
at any stage, were unresponsive to the earlier treatments, 
posed diagnostic dilemmas (eg, an elderly patient who 
has notable memory problems along with depressive 
symptoms or a patient who has hallucinations in addition 
to depressive symptoms), had substantial comorbidity 
with alcohol dependence, had other associated substantial 
medical problems (eg, a patient who has uncontrolled 
diabetes or hypertension in addition to depression), or for 
whom the primary care physician requested a consultation. 
Every facility team was supported by a clinical specialist 
who visited about once a month and was also available for 
consultation on the telephone to discuss cases.
Patients’ discharge was either planned (eg, if they 
were deemed to have recovered) or unplanned (eg, if 
they did not return for reviews despite adherence 
management procedures). 
For the control intervention (enhanced usual care), 
physicians and patients in usual care practices received 
screening results and were given the treatment manual 
prepared for primary care physicians. Physicians were 
allowed to start treatments of their choice. 
Process indicators assessing the ﬁ delity and quality of 
the intervention were obtained from four sources: the 
separate clinical records maintained by the lay health 
counsellor and the clinical specialist, antidepressant 
use from the clinic records, and quality assessments 
done for every component of the intervention. Quality 
assessments for intervention components were made 
by direct observation or through transcripts of sessions, 
and were rated by senior clinicians. The only possible 
process indicator in the enhanced usual care group was 
antidepressant use. 
Primary and secondary outcomes
The primary outcome was the proportion of patients who 
recovered from common mental disorders as deﬁ ned by 
the International Statistical Classiﬁ cation of Diseases and 
Related Health Problems—10th revision (ICD-10) at 
6 months. The secondary outcome was the severity of 
depression and anxiety symptoms, assessed at 6 months.
The primary and secondary outcomes were assessed 
with the CIS-R, which generates two outputs: an ICD-10 
diagnosis derived from a computer algorithm and a total 
score indicating the overall severity of symptoms.21 
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Statistical analyses
Our sample size estimates have been described in detail 
in our protocol.22 Brieﬂ y, we assumed a coeﬃ  cient of 
variation of 0·2; prevalence of common mental disorders 
(as deﬁ ned by ICD-10) of 66% in participants who 
screened positive; and a follow-up of 75% at 6 months. 
The resulting sample size of 100 screen-positive 
participants in 24 clusters provides more than 90% power 
to detect a diﬀ erence in recovery rates of 70% in the 
intervention group versus 50% in the control group 
(enhanced usual care). The higher rates of ICD-10 cases 
and follow-up rates recorded during phase 1 led to a 
downward re-estimation of the sample sizes in phase 2 to 
80 screen-positive participants per cluster. 
All analyses were done in Stata (version 11.0). Participants 
were divided into four a-priori diagnostic groups on the 
Figure: Trial proﬁ le  
CSC=collaborative stepped care. EUC=enhanced usual care. PHC=public primary health centre. GP=general practitioner. CMD=common mental disorder. 
ICD-10=International Statistical Classiﬁ cation of Diseases and Related Health Problems—10th revision. 
49 clusters in PHC facilities assessed for 
eligibility clusters
68 clusters in GP facilities assessed for 
eligibility
32 clusters excluded
32 clusters did not meet inclusion criteria
5 clusters of back-up PHC facilities
10 clusters of back-up GP facilities
46 clusters excluded
       25 clusters did not meet eligibilty criteria
 21 declined to participate
20 352 patients screened
3816 patients screened positive for CMDs using GHQ
2796 patients enrolled (24 clusters)
1648 patients in PHC facilities randomised (12 clusters)
1148 patients in GP facilities randomised (12 clusters)
1436 patients randomly allocated to control 
(EUC; 12 clusters; mean of 115 patients 
per cluster)
1269 patients analysed for 6-month
outcomes (12 clusters; mean of 100 
patients per
cluster)
1017 with ICD-10 CMD
416 with depression
252 subthreshold
1360 patients randomly allocated to
intervention (CSC; 12 clusters; mean 
of 106 patients per cluster)
382 patients not eligible




1160 patients analysed for 6-month
outcomes (12 clusters; mean of 90 
patients per cluster)
944 with ICD-10 CMD
257 with depression
216 subthreshold 
1 cluster of GP facility replaced by back-up
facility
167 lost to follow-up at 6 months (0 clusters)
120 refused to continue
19 emigrated
22 could not be located
6 died 
200 patients lost to follow-up at 6 months
(0 clusters)
121 refused to continue
27 emigrated
45 could not be located
3 died
4 too ill to respond 
5 patients did not receive treatment
5 were too busy
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basis of their clinical diagnosis at baseline. Screen-positive 
cases were all participants in the trial—ie, patients who 
had been assessed with the GHQ-12 and identiﬁ ed to have 
a probable common mental disorder. For these patients, 
identiﬁ cation of a common mental disorder could be 
established through routine screening in primary care; a 
lengthy diagnostic interview would not be feasible because 
of the longer duration needed. ICD-10 cases comprised 
the subgroup of screen-positive patients who had a 
diagnosable CMD assessed with the CIS-R; these patients 
were the primary analysis group. Subthreshold cases were 
the subgroup of screen-positive patients who did not meet 
ICD-10 diagnostic criteria for CMD on the CIS-R. 
Depression cases were the subgroup of ICD-10 patients 
with the speciﬁ c diagnosis of depression, assessed with 
the CIS-R; these cases included patients with comorbidity 
with anxiety.
As per the trial protocol,22 the primary analysis was the 
diﬀ erence across groups in the proportion of patients 
with these disorders who recovered at 6 months at 
baseline according to the ICD-10 criteria (ie, are no longer 
patients). Secondary analyses were also evaluated at 
6 months and comprised the diﬀ erences across groups 
in: the proportion of depression cases who recovered; the 
prevalence of patients who met ICD-10 criteria for 
common mental disorders among screen-positive cases 
and subthreshold cases; and the mean total CIS-R score 
in each diagnostic group. 
Analyses were based on cluster-level summary 
measures, because individual-level regression methods 
are not robust when there are few clusters per group.26 
For binary outcomes, the eﬀ ect was measured by the 
risk ratio and risk diﬀ erence. The stratum-speciﬁ c RRs 
were calculated as the ratio of the geometric mean risks 
between groups for each of the six strata, and the overall 
risk ratio was estimated as the weighted-average of 
these stratum-speciﬁ c RRs. An approximate variance 
for the log (mean risk) in each group was obtained from 
the residual mean square from a two-way analysis of 
variance of community log-risk on strata and study 
group. A 95% CI for the risk ratio was calculated from 
this variance with a stratiﬁ ed t test with 12 degrees of 
freedom.26 Similarly, a 95% CI for the risk diﬀ erence 
was obtained from an analysis of variance of the mean 
risk on strata and study group. For continuous 
outcomes (CIS-R score), the measure of eﬀ ect was the 
mean diﬀ erence between groups, and these outcomes 
were analysed in an analogous method on the basis of 
mean scores in every facility. Secondary planned 
analyses assessed the eﬀ ect of the intervention 
separately in the two types of facilities, with assessment 
of eﬀ ect-modiﬁ cation of the intervention eﬀ ect by 
facility type estimated using Welch’s t test to compare 
log risk ratios in the two groups.27 Predeﬁ ned sensitivity 
analyses included adjustment for age, sex education 
level, and baseline CIS-R score. Finally, we did a 
sensitivity analysis to investigate the eﬀ ect of missing 
data by using multiple imputation with chained 
equations to create multiple datasets, which were 
analysed with an individual level Poisson regression 
model, allowing for within-cluster correlation using 
generalised estimating equations. Analyses were 
completed on an intention-to-treat basis (ie, analysis 
included the 1160 patients randomly assigned to the 
collaborative stepped-care group who were seen at 
6 months and the 1269 patients randomly assigned to 
the enhanced usual care group who were seen at 







PHC 823 (61%) 825 (57%)
GP 537 (39%) 611 (43%)
Baseline diagnostic category 
Subthreshold case 262 (19%) 292 (20%)
ICD-10 case 1098 (81%) 1144 (80%)
Depression case* 304 (22%) 470 (33%)
CIS-R score 19·9 (9 ·1) 19·4 (9·1)
Age (years)
18–29 147 (11%) 147 (10%)
30–39 296 (22%) 275 (19%)
40–49 365 (27%) 368 (26%)
50–59 256 (19%) 278 (19%)
≥60 296 (22%) 368 (26%)
Sex
Male 246 (18%) 245 (17%)
Female 1114 (82%) 1191 (83%)
Marital status†
Never married 96 (8%) 63 (5%) 
Married 761 (64%) 857 (65%) 
Widowed 330 (28%) 378 (29%) 
Separated or divorced 8 (1%) 18 (1%)
Ethnic origin†
Goan 1131 (95%) 1251 (96%) 
Non-Goan 55 (5%) 54 (4%)
Language†
Konkani 1163 (98%) 1292 (99%) 
Other 23 (2%) 13 (1%)
Education (years)†
<1 490 (41%) 657 (50%) 
1–4 221 (19%) 198 (15%) 
≥5 475 (40%) 450 (34%) 
Data are number (%) or mean (SD). CSC=collaborative stepped care. EUC=enhanced 
usual care. PHC=public primary health centre. GP=general practitioner. 
ICD-10=International Statistical Classiﬁ cation of Diseases and Related Health 
Problems—10th revision. CIS-R=revised clinical interview schedule. *Including 
comorbid anxiety disorders. These depression cases are a subset of ICD-10 cases. 
†These variables were asked at the interim 2-month follow-up22 and are based on 
2491 (89%) of participants: 1186 (87%) of those in the CSC group and 1305 (91%) 
in the EUC group. 
Table 2: Baseline characteristics of trial participants, by intervention group 
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Role of the funding source
The sponsors of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. HAW and VP had full access to all 
the data; VP had the ﬁ nal responsibility for decision to 
submit for publication.
Results
The ﬁ gure shows the trial proﬁ le. One GP cluster was 
replaced by a back-up within a month of randomisation 
because of small patient numbers. All 24 clusters were 
followed to the end of the trial 20 352 patients were 
screened, of whom 3816 (18·8%) screened positive for 
common mental disorders and 3434 (16·9%) were eligible 
to participate (ﬁ gure). Of these patients, 1360 were enrolled 
in the collaborative stepped-care group and 1436 in the 
enhanced usual care group. Participants who did not 
consent tended to be younger than those who did consent 
(webappendix p 1). 1160 participants (85%) in the 
collaborative stepped-care group and 1269 (88%) in the 
control group completed the 6-month outcome 
assessment. Participants who were not followed up at 
6 months were more likely to be younger and male; 
however, we noted no diﬀ erences in terms of intervention 
group, facility type, or baseline diagnostic group 
(webappendix p 2).
1098 patients met ICD-10 criteria for common mental 
disorders at baseline in the intervention group (81% of 
patients who screened positive) and 1144 (80%) in the 
control group. Of these, 944 (86%) in the intervention 
group and 1017 (89%) in the control group were seen at 
the 6-month outcome assessment. We recorded little 
intra-cluster correlation (0·03), and the coeﬃ  cient of 
variation (k) for prevalence of these disorders at baseline 
in all patients who screened positive was 0·08.
Table 2 shows the sociodemographic and clinical 
characteristics of the two groups. The trial population was 
mostly female, and the mean age was 46·3 years (SD 13·3). 
Of the 2242 patients (81%) who met ICD-10 criteria for 
these disorders at baseline (1098 in the collaborative 
stepped-care group; 1144 in the enhanced usual care 
group), 774 (35%) had depression, including comorbid 
anxiety disorders (304; 470). The most common diagnosis 
was mixed anxiety-depressive disorder (n=1032; 46% of 
patients with common mental disorders); the remaining 
436 (19%) had a pure anxiety disorder (233; 203). Generally, 
All facilities (primary analysis) PHC GPs p value*
Primary analysis group: patients with ICD-10 CMD (n=1961)
Collaborative stepped care (n=944)† 620 (65·0%) 369 (65·9%) 251 (64·1%) ··
Enhanced usual care (n=1017)† 553 (52·9%) 267 (42·5%) 286 (65·9%) ··
Risk diﬀ erence (95% CI) 12·1% (1·6–22·5) 23·4% (5·0–41·7) –1·8% (–17·7 to 14·1) 0·02
Risk ratio (95% CI); p value 1·22 (1·00–1·47); p=0·05 1·55 (1·02–2·35); p=0·04 0·95 (0·74–1·22); p=0·63 0·02
Secondary analysis group: patients with depression (n=673)
Collaborative stepped care (n=257) 143 (53·6%) 81 (52·1%) 62 (55·1%) ··
Enhanced usual care (n=416) 216 (50·4%) 114 (38·8%) 102 (65·5%) ··
Risk diﬀ erence 95% CI) 3·2% (–9·4 to 15·7) 13·3% (–10·1 to 36·6) –10·4% (–29·0 to 8·1) 0·06
Risk ratio (95% CI); p value 1·05 (0·81–1·36); p=0·69 1·34 (0·73–2·45); p=0·25 0·82 (0·60–1·12); p=0·18 0·07
Prevalence of binary outcomes in each arm was estimated as the geometric mean of the cluster-level prevalences within each arm. CMD=common mental disorder. 
PHC=public primary health centre. GP=general practitioner. ICD-10=International Statistical Classiﬁ cation of Diseases and Related Health Problems—10th revision. *For eﬀ ect 
modiﬁ cation by facility type. †Excluding subthreshold cases. 
Table 3: Eﬀ ect of intervention on recovery from ICD-10-conﬁ rmed CMDs and depression at 6 months, by diagnostic group at baseline 
All facilities (primary analysis) PHC GPs p value*
Screen-positive cases (n=2429)
Collaborative stepped care (n=1160) 354 (28·8%) 196 (27·7%) 158 (29·9%) ··
Enhanced usual care (n=1269) 541 (38·6%) 375 (50·8%) 166 (29·4%) ··
Risk diﬀ erence (95% CI) –9·9% (–19·4 to 0·03) –23·1% (–42·1 to 4·2) –0·05% (–12·9 to 14·0) 0·02
Risk ratio (95% CI); p value 0·76 (0·57 to 1·02); p=0·06 0·54 (0·37 to 0·81); p=0·01 1·07 (0·66 to 1·74); p=0·76 0·02
Subthreshold cases (n=468)
Collaborative stepped care (n=216) 30 (12·7%) 20 (12·4%) 10 (13·0%) ··
Enhanced usual care (n=252) 77 (25·0%) 49 (31·2%) 28 (19·9%) ··
Risk diﬀ erence (95% CI) –12·3% (–23·5 to 1·1) –18·8% (–46·6 to 9·0) –6·9% (–19·3 to 5·5) 0·33
Risk ratio (95% CI); p value 0·52 (0·29 to 0·96); p=0·04 0·40 (0·11 to 1·38); p=0·11 0·70 (0·31 to 1·59); p=0·35 0·31
Prevalence of binary outcomes in each arm was estimated as the geometric mean of the cluster-level prevalences within each arm. PHC=public primary health centre. 
GP=general practitioner. ICD-10=International Statistical Classiﬁ cation of Diseases and Related Health Problems—10th revision. *For eﬀ ect modiﬁ cation by facility type. 
Table 4: Eﬀ ect of intervention on prevalence of ICD-10-conﬁ rmed CMDs at 6 months, by diagnostic group and facility type at baseline (secondary analyses)
See Online for webappendix
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distribution of these disorders between groups was 
similar; although participants in the enhanced usual care 
group were more likely to have depression, the proportion 
of patients with these disorders according to ICD-10 and 
mean CIS-R scores were similar (table 2).
The collaborative stepped-care intervention had a small 
eﬀ ect on recovery for patients who met ICD-10 criteria 
for common mental disorders at 6 months (table 3). The 
eﬀ ect was larger in PHC participants and not evident in 
GP participants (table 3). The intervention had no 
signiﬁ cant eﬀ ect on recovery from common mental 
disorders in patients with depression (table 3). The eﬀ ect 
on recovery from common mental disorders persisted 
when missing values were imputed (risk ratio 1·19, 
95% CI 1·02–1·40 on imputed analysis vs risk ratio 1·22, 
95% CI 1·00–1·47 on complete case analysis). The 
number needed to treat for the overall primary outcome 
was eight (95% CI 4–63), which was four in the PHC 
clinics (95% CI 2–20).
There was modest evidence of an eﬀ ect on the overall 
prevalence of common mental disorders at 6 months in 
screen-positive cases, with prevalence halved in PHCs, 
although there was no eﬀ ect in GP facilities (table 4). In 
the subthreshold cases, there was evidence of a protective 
eﬀ ect of the intervention overall, which did not diﬀ er by 
facility type (table 4).
For each diagnostic group, the mean CIS-R score was 
lower in the collaborative stepped-care than in the 
enhanced usual care group at 6 months (table 5). 
Furthermore, in the screen-positive cases, the intervention 
had a positive eﬀ ect in PHCs for patients who met ICD-10 
criteria for common mental disorders, and weak evidence 
of a positive eﬀ ect for patients with depression, although 
it had no eﬀ ect in GP facilities (table 5).
Adjustment for baseline factors made little diﬀ erence 
to all the ﬁ ndings (data not shown).
Mean 




PHC GPs p value*
ICD-10-conﬁ rmed cases 
Collaborative stepped care 22·93 (7·31) 9·30 (–59%) 9·28 (–58%) 9·33 (–61%) ··
Enhanced usual care 22·56 (7·16) 11·61 (–48%) 14·12 (–38%) 9·10 (–58%) ··
Mean diﬀ erence (95% CI); p value for 
diﬀ erence
–2·14 (–4·32 to 0·04); 0·05 –4·84 (–8·48 to –1·20); 0·02 0·63 (–2·76 to 4·02); 0·68 0·01
Depression cases
Collaborative stepped care 28·31 (6·90) 11·38 (–60%) 11·30 (–58%) 11·47 (–62%) ··
Enhanced usual care 26·58 (7·06) 12·54 (–53%) 15·59 (-41%) 9·48 –65%) ··
Mean diﬀ erence (95% CI); p value –1·01 (–3·63 to 1·61); 0·42 –4·30 (–9·58 to 0·98); 0·09 2·38 (–1·29 to 6·05); 0·17 0·02
Screen-positive cases 
Collaborative stepped care 20·03 (9·05) 8·56 (–57%) 8·39 (–56%) 8·72 (–59%) ··
Enhanced usual care 19·49 (8·99) 10·87 (–44%) 13·14 (–34%) 8·60 (–55%) ··
Mean diﬀ erence (95% CI); p value –2·15 (–4·20 to –0·10); 0·04 –4·75 (–8·86 to –0·64); 0·03 0·52 (–2·36 to 3·40); 0·69 0·02
Subthreshold cases
Collaborative stepped care 7·37 (3·01) 5·63 (–27%) 5·69 (–24%) 5·56 (–31%) ··
Enhanced usual care 7·10 (3·10) 7·62 (5%) 8·57 (–22%) 6·68 (–11%) ··
Mean diﬀ erence (95% CI); p value –1·90 (–4·01 to 0·20); 0·07 –2·87 (–8·09 to 2·34); 0·20 –0·91 (–3·25 to 1·44); 0·40 0·38
PHC=public primary health centre. GP=general practitioner. ICD-10=International Statistical Classiﬁ cation of Diseases and Related Health Problems—10th revision. 
CIS-R=revised clinical interview schedule. *For eﬀ ect modiﬁ cation by facility type. 
Table 5: Eﬀ ect of intervention on severity of symptoms (mean CIS-R score at individual level [% diﬀ erence; SD]) at 6 months, by diagnostic group and 
facility type at baseline (secondary analyses)






Proportion of screen-positive patients who meet 
ICD-10 criteria for common mental health disorders
Minimum 66% 78% 84% 81 (79–83)
Proportion of patients who receive at least ﬁ rst 
psychoeducation session 
Minimum 90% 95% 98% 96 (95–97)
Proportion of moderate to severe cases who receive 
antidepressant drugs
Minimum 80% 83% 88% 85 (82–88)
Proportion of all patients who receive 
antidepressant treatment
NA 48% 64% 54 (51–57)
Proportion of patients receiving antidepressant 
drugs who complete at least 3 months of treatment
Minimum 50% 53% 52% 53 (49–56)
Proportion of moderate to severe cases who receive 
interpersonal psychotherapy
NA 5% <1% ··
Proportion of patients receiving interpersonal 
psychotherapy who complete at least six sessions 
Minimum 50% 33% 0% ··
Proportion of patients who had a planned 
discharge
Minimum 60% 51% 67% 57 (54–60)
Proportion of patients referred to psychiatrist Maximum 5% <1% <1% 0·5 (0·3–1·1)
PHC=public primary health centre. GP=general practitioner. ICD-10=International Statistical Classiﬁ cation of Diseases 
and Related Health Problems—10th revision. NA=not available/applicable.
Table 6: Process indicators of ﬁ delity and quality for intervention facilities 
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The original target for coverage was reached for most 
indicators (table 6), although among patients receiving 
interpersonal psychotherapy the proportion who completed 
at least six sessions was lower than expected. A major 
barrier was the indirect and direct costs associated with the 
requirement for patients to return to the facility for regular 
sessions. More than half of all patients had a planned 
discharge from the programme. The number of quality 
assessments also exceeded the targets set for the trial (data 
not shown). In the control group, of those on antidepressant 
drugs, 45 (10·2%) completed 3 months of treatment in the 
PHC phase and 34 (11·3%) in GP phase. 
There were seven serious adverse events (three deaths 
and four suicide attempts) in the collaborative stepped-
care group and 12 in the enhanced usual care group (six 
deaths and six suicide attempts). None of the deaths were 
from suicide. 
Discussion
Findings from this study have shown that overall there 
was modest evidence for a beneﬁ cial eﬀ ect of the 
intervention on recovery from common mental disorders 
at 6 months according to the ICD-10 criteria, with a 
statistically signiﬁ cant eﬀ ect in PHCs but no eﬀ ect in 
private facilities. We recorded no eﬀ ect of the intervention 
on the smaller subgroup of patients with depression. 
Secondary analyses showed that the intervention had a 
consistent eﬀ ect in PHCs but not in private facilities for 
all baseline diagnostic groups apart from depression. 
The intervention also suggested some preventive eﬀ ect 
in reducing the prevalence of common mental disorders 
in subthreshold cases. 
The results of the MANAS trial indicate that such a 
collaborative-stepped care intervention delivered by 
trained lay health counsellors can improve recovery 
rates for patients with common mental disorders in 
public primary care settings, but not in private primary 
care settings. The recorded eﬀ ects might underestimate 
the true eﬀ ect because two key components of the 
intervention (provision of screening results to patients 
and physicians, and evidence-based guidelines to the 
physician) were oﬀ ered in both groups. The recovery 
rates in the intervention groups in both types of facilities 
are similar to those reported by other trials (panel) and 
to our original hypothesis.22 We recorded similar 
recovery rates in the private GP control group; thus, 
private GPs do well irrespective of presence of a lay 
health counsellor. By contrast, PHCs beneﬁ t from the 
addition of a lay health counsellor, and the intervention 
appeared eﬀ ective for the treatment and prevention of 
common mental disorders. 
There are several possible explanations for these 
results. Although the PHC facilities were indicative of 
typical centres, having been selected randomly from the 
eligible sampling frame, the participating GPs were 
likely to represent a subgroup of physicians who were 
motivated to improve the quality of care for common 
mental disorders because of the diﬃ  culties in obtaining 
a representative sampling frame. Other explanations 
could include the style of GP interactions with patients, 
which might have similar characteristics to that of the 
lay health counsellors (eg, better continuity of care with 
the same physician). By contrast, in the PHCs, larger 
numbers of patients tend to be seen for shorter periods 
by a doctor and the privacy needed to discuss 
interpersonal diﬃ  culties is not assured. This diﬀ erence 
has also been reported in the WHO international study3 
of common mental disorders in general health-care 
settings, which categorised primary care facilities into 
two distinct types: individual, personalised client-centred 
care model; and a collective clinic-centred care model. 
The personalised types of health-care settings showed 
better performance indicators than did the collective 
model, suggesting that the organisation of health care 
might directly aﬀ ect the outcomes. We are investigating 
these hypotheses through qualitative interviews with 
GPs to ascertain the extent to which usual care by these 
GPs approximated the care provided by the lay health 
counsellors. Finally, characteristics of patients diﬀ ered 
by clinic type (webappendix p 3). The absence of an 
overall eﬀ ect in the subgroup of patients with depression 
might be partly attributable to lower power to detect a 
clinically signiﬁ cant eﬀ ect in this subgroup, inadequate 
guidelines to triage depression cases, and inadequate 
intensity of the treatments, particularly the failure to 
deliver interpersonal psychotherapy as planned. Future 
analyses will assess the eﬀ ect of the intervention at 
short-term and long-term secondary endpoints. 
The strengths of this trial include: large samples from 
rural and urban populations with inclusion of both 
public and private facilities; high follow-up rates; high 
levels of ﬁ delity and quality of the intervention (with the 
exception of low coverage of interpersonal psycho-
therapy); and consistent documentation of eﬀ ect in 
PHCs for each diagnostic group apart from depression. 
Panel: Research in context
Systematic review
Systematic reviews show that antidepressant drugs and brief 
psychological treatments are eﬀ ective for the treatment 
of common mental disorders28 and that collaborative 
stepped-care models are eﬀ ective for their delivery in primary 
health care.15 
Interpretation
The results of the MANAS trial suggest that a collaborative 
stepped-care intervention provided by trained lay health 
counsellors can improve recovery rates for patients with 
common mental disorders in public primary care settings, 
which are characterised by a collective clinic-centred model of 
care. However, the results of this trial indicate that this 
intervention is not eﬀ ective for private primary care settings, 
characterised by a personalised client-centred model of care. 
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Additionally, we were able to conﬁ rm the high speciﬁ city 
of our screening procedure in a real-world context. 
About 13% of patients were not seen at the 6-month 
outcome, and these patients were more likely to be 
younger and male. However, separate models by age-
group and sex were ﬁ tted, and showed no evidence of 
diﬀ erential recovery rates by sex or age. Missing data are 
thus unlikely to aﬀ ect the results. 
We recommend that the collaborative stepped-care 
intervention should be extended to clinics run by public 
primary health-care facilities. Screening is feasible 
because of the high prevalence of common mental 
disorders in primary care attenders, the brevity of 
screening instruments29 and increasing literacy rates in 
many countries that makes self-completion feasible, 
and, as we noted, a relatively high speciﬁ city of diagnosis 
of these disorders by ICD-10 criteria. Screening might 
have been a crucially important component accounting 
for the good outcomes in the control GP facilities. Lay 
health counsellors could undertake several health-care 
roles, are fairly low cost to recruit, and are readily 
available in most developing countries. However, the 
fact that the intervention had no eﬀ ect on the smaller 
subgroup of patients with depression also indicates the 
need for feasible methods for its detection and for more 
intensive treatments for these patients—for example, 
psychological treatments that are more speciﬁ c to the 
needs of the patient or more aggressive pharma co-
therapy.30 In conclusion, results from the MANAS trial 
indicate the eﬀ ectiveness of a lay health counsellor-led 
collaborative stepped-care intervention for common 
mental disorders in public primary health-care 
facility attenders in India. This evidence should be used 
to improve services for common mental disorders in 
settings for which mental health professionals 
are scarce. 
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